Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. IGEA Pharma N.V.
  6. News
  7. Press Releases
    IGPH   NL0012768675

IGEA PHARMA N.V.

(IGPH)
  Report
Delayed Swiss Exchange  -  12:30:21 2023-03-24 pm EDT
0.0120 CHF   +9.09%
03/13Igea Pharma N : Convening notice & Agenda
PU
2022Igea Pharma N : appoints new Chief Financial Officer
PU
2022Igea Pharma N : Minutes of the AGM 1 December 2022
PU
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société IGEA PHARMA N.V.
03/13Igea Pharma N : Convening notice & Agenda
PU
2022Igea Pharma N : appoints new Chief Financial Officer
PU
2022Igea Pharma N : Minutes of the AGM 1 December 2022
PU
2022Igea Pharma N : announces annual General Meeting Resolutions
PU
2022Igea Pharma N.v. : Igea discloses its 2022 Half-Year Financial Report
EQ
2022Igea Pharma N.v. : Igea discloses its 2021 annual report
EQ
2022Igea Pharma N : Convening Notice and Agenda
PU
2022Igea Pharma N.v. : IGEA to get SIX approval to the semi-annual 2022 report disclosure
EQ
2022Igea Pharma N : to get SIX approval to the semi-annual 2022 report disclosure
PU
2022Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022Igea Pharma N : to get SIX further approval to the 2021 annual report disclosure
PU
2022Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022Igea Pharma N.v. : Igea pharma has announced that lmh - an industrial holding company - ha..
EQ
2022Igea Pharma N : Notice to postpone annual general meeting IGEA Pharma N.V.
PU
2022Igea Pharma N : Note of the Board
PU
2022Igea Pharma N.v. : IGEA to get SIX further approval to the 2021 annual report disclosure
EQ
2022Igea Pharma N.v. : Igea pharma has signed a preliminary agreement with lmh-an industrial h..
EQ
2022Igea Pharma N.v. : IGEA to get SIX approval to delay the 2021 annual report disclosure
EQ
2022Igea Pharma N : to get SIX approval to delay the 2021 annual report disclosure
PU
2022Igea Pharma N : non-executive board members resigned after completion of the first post-co..
PU
2021Igea Pharma N : GBC Research report IGEA Pharma N.V.
PU
2021Igea Pharma N : GBC AG Publishes initial equity research report with buy recommendation an..
PU
2021Igea Pharma N.v. : Gbc ag publishes initial equity research report with buy recommendation..
EQ
2021Igea Pharma N : GBC AG to start equity coverage of IGEA Pharma
PU
2021Igea Pharma N : discloses its half-2021 financials
PU
2021Igea Pharma N : has been granted the listing of the new shares from SIX Exchange Regulatio..
PU
2021Igea Pharma N : to submit the listing prospectus to the SIX following the business combina..
PU
2021Igea Pharma N : to boost revenues entering the growing cannabis market
PU
2021Igea Pharma N : Minutes of the AGM 9 July 2021 + Attendance list
PU
2021Igea Pharma N : announces Annual General Meeting resolutions
PU
2021Igea Pharma N : To launch the all equity offer to blue sky natural resources ltd.
EQ
2021Igea Pharma N : Convening notice and agenda
PU
2021Igea Pharma N : announces changes in its board and other corporate updates
EQ
2021Igea Pharma N : announces changes in its board and other corporate updates
PU
2021Igea Pharma N : disclosed its Annual Report 2020
EQ
2021Igea Pharma : Annual report
PU
2021Igea Pharma N : disclosed its Annual Report 2020
PU
2021Igea Pharma N : to get SIX approval to delay the 2020 annual report disclosure
EQ
2021Igea Pharma N : to get SIX approval to delay the 2020 annual report disclosure
PU
2021Igea Pharma N : announces extraordinary general meeting results
EQ
2021Igea Pharma N : announces extraordinary general meeting results
PU
2021Igea Pharma N : Minutes of the EGM 28 April 2021
PU
2021Igea Pharma N : to secure convertible bond commitment with Negma Group
PU
2021Igea Pharma N : to secure convertible bond commitment with Negma Group
EQ
2021Igea Pharma N : and its CFO end collaboration
EQ
2021Igea Pharma N : and its CFO end collaboration
PU
2021Igea Pharma N : Convening notice
PU
2021Igea Pharma N : to finalize on convertible bond facility arrangement
PU
2021Igea Pharma N : calls extraordinary general meeting
PU
2021Igea Pharma N : announces three new board members
EQ
2021Igea Pharma N : announces three new board members
PU
2021Igea Pharma N : calls extraordinary general meeting
EQ
2021Igea Pharma N : announces changes in its board
PU
2021Igea Pharma N : announces changes in its board
EQ
2021Igea Pharma N : to update on business combination
EQ
2020Igea Pharma N : ensures ‘Alz1' supply for the EU market
PU
2020Igea Pharma N : announces changes in its board
EQ
2020Igea Pharma N : discloses its half-2020 financials
EQ
2020Igea Pharma N : discloses its half-2020 financials
PU
2020Igea Pharma N : and Blue Sky Natural Resources to combine businesses
EQ
2020Igea Pharma N : announces changes in its board
EQ
2020Igea Pharma N : announces changes in its board
PU
2020Igea Pharma N : announces annual general meeting resolutions
PU
2020Igea Pharma N : Minutes of the EGM 3 July 2020
PU
2020Igea Pharma N : announces annual general meeting resolutions
EQ
2020Igea Pharma N : announces changes in its board
EQ
2020Igea Pharma N : disclosed its Annual Report 2019
EQ
2020Igea Pharma N : Miami University confirms high quality of IGEA's COVID-19 rapid test
EQ
2020Igea Pharma N : to partner with Acalis for Alz1 wholesale distribution in the US
EQ
2020Igea Pharma N : receives approval from SIX Exchange Regulation to delay the publication of..
EQ
2020Igea Pharma N : supplies COVID-19 antibody-based test in the US
EQ
2020Igea Pharma N : supplies COVID-19 antibody-based test in the US
EQ
2020Igea Pharma N : support Italian COVID-19 battle
EQ
2019Igea Pharma : Alz1 Launches the First At-Home Solution to Detect, Help Reduce Risk Factor ..
BU
Upcoming event on IGEA PHARMA N.V.
04/28/23FY 2022 Earnings Release
Upcoming sector events
04/07/23SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. : FY 2022 Earnings Release
04/25/23SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. : Q1 2023 Earnings Release (Projected)
05/03/2310X GENOMICS, INC. : Q1 2023 Earnings Release (Projected)
05/04/23NATERA, INC. : Q1 2023 Earnings Release (Projected)
Sector
Healthcare
Healthcare Services
 Healthcare Equipment & Supplies
  Medical Equipment, Supplies & Distribution
   Diagnostic & Testing Substances
Stock markets for all
100% Free Registration
fermer